Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
CRISPR Therapeutics (NASDAQ:CRSP) said Monday that Vertex Pharmaceuticals (VRTX) subsidiary ViaCyte has elected to opt-out of their development partnership for gene-edited stem cell therapies for the ...
According to The New England Journal of Medicine, investigators at Uppsala University Hospital implanted a product called ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
One of the biggest opportunities in healthcare today centers around genome editing. According to analysts at Grand View Research, the global genome market is expected to expand at a compound annual ...
Cathie Wood added to her positions in Amazon, MercadoLibre, and CRISPR on Monday. Amazon has been moving higher since posting well-received quarterly results last week. MercadoLibre and CRISPR offered ...
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback